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1. Introduction 65 
For such a relatively small portion of the human genome, mitochondrial DNA (mtDNA) exhibits 66 
extraordinary variability and unique features. The size of human mitochondrial genome approximates 67 
16,569 basepairs (bp; length may slightly vary due to insertions and deletions), which is on a scale of 68 
about 1:200,000 compared to the nuclear DNA. Despite its diminutiveness, mtDNA is essential for 69 
cellular energy production and, thus, presents a vital part of our genome. It is enclosed within double-70 
layered membranes of cell’s energy factories – mitochondria. Due to its well-protected location, as 71 
well as circular nature, and the fact that there may be as many as several thousand copies of mtDNA 72 
per one cell (as opposed to nuclear DNA, present only in two copies per cell), this small genome is 73 
more resistant to environmental conditions and degradation than nuclear DNA. Therefore, it may well 74 
be the only source of genetic information recoverable in some cases, and even though it may not be 75 
used for individual identification (as all maternal relatives have the same mitochondrial genome 76 
sequence, with tolerable variations in indels and heteroplasmies), it is certainly preferable to no result 77 
at all. The aforementioned characteristics have established mtDNA as a valuable source in many fields 78 
of science, such as evolutionary biology, molecular anthropology, forensics etc. [1]. 79 
Until fairly recently, the only part of mtDNA extensively investigated was the control region (CR), 80 
approximately 1100 bp in length, encompassing the origin of replication, other regulatory elements 81 
and hypervariable regions (or segments; HVS-I, HVS-II and HVS-III). The most of mitochondrial 82 
sequence variation is concentrated in HVS, and mtDNA CR analysis by Sanger-type sequencing (STS) 83 
has become the gold standard employed in routine forensic casework, where sample material is scarce 84 
and challenging to process for various reasons (degradation, inhibitors, etc.). However, CR equals only 85 
around 7% of complete mitochondrial genome, and in cases of more common mitochondrial 86 
haplotypes, this information alone cannot provide the resolution sufficient for forensic purposes [2]. 87 
Therefore, sequencing of the entire mtDNA clearly has great value, as inter-individual variation comes 88 
to the fore by revealing all 16,569 bp length of genetic information. Besides ethical and legal issues 89 
which stem from accessing the coding region sequence, analysis of whole mitochondrial genomes was 90 
simply not feasible previously with Sanger sequencing method, as it was costly, laborious, time-91 
consuming and nearly impossible to apply on a large scale – few studies endeavoured to employ STS 92 
to produce whole mtDNA data (e.g. [3, 4]). In addition, population samples usually contain abundance 93 
of genetic material of high quality, whereas forensic casework samples rarely come in such pristine 94 
state, meaning STS of whole mtDNA would be even more difficult in the latter case. 95 
Over the recent years we have witnessed great technological leaps that brought about next generation 96 
of sequencing platforms and chemistries, or rather as it is more commonly called, the massively 97 
parallel sequencing (MPS). It has advanced research in many areas of biology, including forensic 98 
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science [5], where the focus of forensic genetics is gradually shifting from allele length-based 99 
identification to sequence variants, enabling even better power of discrimination. The field is being 100 
transformed into forensic genomics, since the sequencing of entire genomes (nuclear and/or 101 
mitochondrial) is not unachievable feat in routine laboratory workflow anymore. The true challenge 102 
is to assemble all steps of the sequencing protocol into a single workflow, suited for particular study, 103 
with sequencing data analysis being a singular challenge on its own [6]. Analysis and reporting for 104 
forensic purposes relies on compliance with internationally agreed and prescribed guidelines, 105 
wherefore the method needs to be evaluated through internal validation performed by each 106 
laboratory [5, 7, 8]. Current mtDNA guidelines [9, 10] have been updated to some extent to 107 
accommodate MPS methods, and will certainly undergo further refinements as more and more MPS 108 
data are generated. Various studies have already shown repeatability, reproducibility, concordance to 109 
STS data, and overall reliability of MPS assays for analysis of whole mtDNA [11-17]. However, their 110 
approach to data analysis and interpretation differed, with bioinformatics solutions encompassing 111 
commercially available software, free online software, in-house developed and tailored pipelines, 112 
along with almost as diverse threshold settings. 113 
In this work, we evaluated Illumina® Human mtDNA Genome assay on MiSeq FGxTM benchtop 114 
sequencer, in conjunction with BaseSpace® Sequence Hub applications for mtDNA analysis (namely, 115 
mtDNA Variant Processor and mtDNA Variant Analyzer). The assay is based on Nextera® XT library 116 
preparation, which consists of target enrichment by long-range PCR (mtDNA amplified in two 117 
overlapping amplicons), fragmentation and tagging (performed by Nextera® XT transposome), dual 118 
index barcoding, and subsequent library purification and normalization. Libraries are pooled, 119 
denatured and diluted prior to loading on instrument, to undergo paired-end sequencing-by-synthesis 120 
reactions. From there, it is natural to proceed with data analysis in Illumina’s bioinformatics online 121 
platform, thus streamlining the workflow and enabling faster data processing. We present here our 122 
approach to setting analysis and interpretation thresholds for the whole mtDNA analysis workflow, as 123 
well as evaluation of the entire workflow. Internal interpretation guidelines were developed herein, 124 
defined by multiple components of the thresholds (encompassing read depth, allele percentages and 125 
quality), but the underlying principles of the approach hold potential for wider application in other 126 
similar MPS workflows. Our aim was to establish a reliable system suitable for sequencing complete 127 
mitochondrial genomes from high-quality samples of the type to be used for population study (i.e. 128 
buccal swab samples and blood), which is one of the prerequisites for using mitochondrial sequence 129 





2. Materials and Methods 133 
2.1. Sample collection and plan of experiments 134 
For the purpose of this study, reference samples were collected from 11 volunteers. All participants 135 
gave detailed informed consent. From each person, two types of samples were collected: buccal swabs 136 
(collected on WhatmanTM Sterile Omniswab, GE Healthcare, UK) and blood (collected on WhatmanTM 137 
FTATM Classic Cards, GE Healthcare, UK). DNA was extracted from buccal swabs using the EZ1® DNA 138 
Investigator® kit on EZ1® Advanced XL instrument (Qiagen, Hilden, Germany), following the 139 
manufacturer’s instructions [18]. As for dried blood on FTATM Cards, QIAamp® DNA Micro Kit (Qiagen, 140 
Hilden, Germany) was used for DNA extraction, also according to the manufacturer’s instructions [19]. 141 
All DNA extracts were subsequently quantified on QubitTM 3.0 Fluorometer using QubitTM dsDNA High 142 
Sensitivity kit (Thermo Fisher Scientific, Waltham, MA, USA). Apart from the collected reference 143 
samples, Standard Reference Material® (SRM) 2392 and 2392-I from National Institute of Standards 144 
and Technology (NIST, Gaithersburg, MD, USA) [20, 21] were obtained. Of those, SRM® 2392 145 
Component #1 CHR (abbreviated as SRM-C) and SRM® 2392-I HL-60 (abbreviated as SRM-H) were used 146 
as positive controls (i.e. probative samples). To monitor the presence of contamination and to assess 147 
the level of experimental and instrument noise, negative controls were introduced in each step of the 148 
workflow: reagent blanks in DNA extraction (NC-EX), as well as in long-range PCR (NC-PCR) and in 149 
library preparation (NC-LIB). 150 
Plan of experiments and samples used are described in Supplementary Table S1. They were designed 151 
to encompass the following studies: repeatability (Supplementary Table S1a), reproducibility 152 
(Supplementary Table S1b), mixtures study (Supplementary Table S1c), concordance MPS to MPS, as 153 
well as concordance MPS to STS (Supplementary Table S1d). Simulated mixed samples were obtained 154 
by combining two persons’ buccal swab sample DNA extracts in a particular ratio (0.5%, 1.0%, 2.5% 155 
and 5.0%; Supplementary Table S1c) prior to enrichment and library prep. In mixtures study, the 156 
sensitivity of minor contributor detection was assessed, but also repeatability, since there were three 157 
replicates for each ratio of contributors. Contamination study consisted of analysing negative controls 158 
(NCs) from all sequencing runs (including, but not limited to these studies only). The general idea was 159 
to use NCs to assess the noise level and characteristics, along with assessment of noise and errors in 160 
replicates of positive controls SRM-C and SRM-H. From this information, analysis and interpretation 161 
thresholds would be calculated, and subsequently applied to other samples included in the evaluation 162 
in order to test parameters of repeatability and reproducibility of the assay. 163 
  164 
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2.2. Target enrichment, library preparation and sequencing 165 
Long-range PCR approach was adopted to obtain whole mitochondrial genomes in two overlapping 166 
amplicons. Primer pairs described in [22] were used (MTL-F1, MTL-R1, MTL-F2 and MTL-R2) to produce 167 
amplicons of sizes 9.1 kbp and 11.2 kbp, with the overlap covering the entire mtDNA control region. 168 
PrimeSTAR® GXL (TaKaRa, Kusatsu, Japan) was used for long-range PCR, with the following thermal 169 
cycling conditions: 25 cycles x [98°C 10 sec + 60°C 15 sec + 68°C 9 min 6 sec] for 9.1 kbp fragment, and 170 
25 cycles x [98°C 10 sec + 68°C 10 min] for 11.2 kbp fragment. Input into target enrichment was 1 ng 171 
of genomic DNA extract in total reaction volume of 12.5 μL, or 2 ng in reaction volume of 25 μL, 172 
otherwise prepared according to manufacturer’s instructions [23]. Quality of PCR products was 173 
evaluated via agarose gel electrophoresis: 1% agarose gel, with the addition of 1 μL Midori Green 174 
Advanced DNA Stain (Nippon Genetics Europe GmbH, Düren, Germany), was run for 45 minutes, 80 175 
V, in SubCell® GT system (Bio-Rad, Hercules, CA, USA). Gels were visualized via GelDocTM system and 176 
Image LabTM software (Bio-Rad, Hercules, CA, USA), whereupon they were inspected for yield, as well 177 
as for expected band size and specificity. In case of any artefacts observed by gel electrophoresis, long-178 
range PCR was repeated for the affected sample. PCR products were quantified with QubitTM dsDNA 179 
High Sensitivity kit, and were then normalized in a two-step manner with ultra-filtered water and 180 
resuspension buffer (RSB, Illumina®) down to the final concentration of 0.2 ng/μL. Equal volumes of 181 
both mtDNA amplicons were pooled for each sample, resulting in a single tube per sample, now 182 
containing entire mtDNA in two fragments. Total amount of 1 ng of each sample was taken further for 183 
library preparation, as per protocol [22]. 184 
Libraries were prepared using Nextera® XT Library Prep Kit (Illumina, San Diego, CA, USA) according to 185 
the manufacturer’s instructions [22]. Briefly, DNA was enzymatically fragmented and tagged with 186 
adapter oligonucleotides in a single reaction (tagmentation) performed by Nextera® XT transposome. 187 
Afterwards, Index 1 (i7) and Index 2 (i5) adapters were added to the tagged DNA in limited-cycle PCR. 188 
Indexed libraries underwent bead-based purification with Agencourt AMPure XP magnetic beads 189 
(Beckman Coulter, Brea, CA, USA). Afterwards, either bead-based normalization or individual 190 
normalization was applied. In the former, libraries were normalized using LNA1/LNB1 magnetic beads 191 
solution (components provided in Nextera® XT Library Prep Kit) as described in the protocol [22], while 192 
in the latter case libraries were quantified with LabChip® DNA High Sensitivity Assay on LabChip® GX 193 
Touch HT (PerkinElmer, Waltham, MA, USA) and then individually normalized to 2-3 nM using RSB. 194 
Normalized libraries were pooled in batches of 24-48 samples per run, denatured and diluted as 195 
described in Illumina® protocol [24], with a 5% spike-in of PhiX Sequencing Control v3 (Illumina, San 196 
Diego, CA, USA). Paired-end sequencing was performed on Illumina® MiSeq FGxTM instrument using 197 
MiSeq® Reagent Kit v2, standard flow-cell, 300 cycles (2 x 151 bp). 198 
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As part of concordance study, separate set of libraries (48 in total) was prepared using Nextera® XT 199 
Library Prep Kit from the same PCR amplicons that were used for repeatability, reproducibility and 200 
mixtures study. Libraries were further processed in an independent laboratory by their staff: they 201 
were quantified with Agilent High Sensitivity DNA Kit on Agilent 2100 Bioanalyzer (Agilent 202 
Technologies, Santa Clara, CA, USA) according to the manufacturer’s instructions, and were 203 
subsequently normalized and pooled for sequencing on Illumina® NextSeq®500 platform following 204 
protocol as described in [25]. NextSeq®500/550 Mid Output Kit v2.5, 150 cycles, was used for paired-205 
end sequencing (2 x 75 bp). Resulting haplotypes from both MPS platforms were compared to each 206 
other for concordance, as well as to Sanger-type sequencing (STS) results generated and described 207 
previously [26]. 208 
 209 
2.3. Data analysis 210 
On MiSeq FGxTM instrument, software Real-Time Analysis (RTA) v.1.18.54 and MiSeq® Reporter 211 
v.2.5.1.3 (Illumina®) provided primary and secondary analysis of sequencing results, applying the 212 
“mtDNA workflow” as specified in sample sheet settings prior to each run. Quality metrics were 213 
reviewed in Illumina® Sequencing Analysis Viewer (SAV) v.1.11.1 software. FASTQ files generated by 214 
MiSeq® Reporter were extracted and uploaded to Illumina® BaseSpace® Sequence Hub online 215 
platform, where they were processed by BaseSpace® mtDNA Variant Processor v1.0.0 App [27]. The 216 
application performs adapter trimming, alignment to circular reference genome, realignment of 217 
regions with indels, removal of primer contribution from reads, variant calling, read filtering and 218 
quality scoring, and generation of output files (e.g. BAM and VCF). Of the few settings that could be 219 
user-defined in mtDNA Variant Processor, common settings that were applied to all analyses 220 
comprised: minimum basecall quality score for a call = 30, and genome used for alignment = rCRS 221 
(revised Cambridge reference sequence) [28, 29]. Values for analysis and interpretation thresholds 222 
(AT and IT, respectively) varied: the first stage of analysis encompassed negative and positive controls 223 
analysed at AT = 0.1%, IT = 0.1%, and minimum read count = 2 (Fig. 1). This way all signals, both true 224 
variants and false positives (noise signals and errors), were detected and taken into consideration for 225 
the calculation of thresholds, as well as for noise level assessment and characterization. All signals 226 
detected in negative controls were treated as noise originating from reagents (DNA extraction, long-227 
range PCR, library preparation, sequencing) and/or instrument detection. Calculated values were 228 
expressed as number of reads (read depth, DP) and included the following: minimum (MIN), maximum 229 
(MAX), average (AV), standard deviation (SD), limit of detection (LOD) and limit of quantitation (LOQ) 230 
– applying principles similar to assessing thresholds in STR markers’ analysis in capillary 231 
electrophoresis [30]. 232 
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Afterwards, samples of positive control samples (SRMs) were analysed in a two-fold manner: 233 
1) data from known variants assigned to controls’ haplotypes (according to [31]) were used to 234 
calculate parameters of variant quality (known as “GQ” in genome VCF files, or “Q score” in 235 
BaseSpace mtDNA Variant Analyzer reports) and percentage of homoplasmic variant (i.e. 236 
percentage required of a base in order to classify the position as homoplasmic); 237 
2) signals detected from all other variants not belonging to the defined haplotypes (both identical 238 
to, or differing from, rCRS) were perused similarly as in negative controls, to estimate noise level 239 
within positive controls, as well as to calculate minimum criteria for reliable variant analysis and 240 
interpretation (read depth and percentages of minor alleles), which would eventually constitute 241 
analysis and interpretation thresholds. 242 
Overall results were used to estimate our internal analysis thresholds in terms of: minimum read depth 243 
for a reliable variant call, percentage of allele for genotype allele (i.e. calling of a homoplasmic variant 244 
at particular position), percentage of alternative allele (for point heteroplasmy calls), and genotype 245 
quality score (GQ; in Phred scale). Thus, internal analysis thresholds (INT) consisted of several 246 
components, which all variants had to comply with in order to produce a valid call. 247 
Second stage of analysis consisted of applying the newly calculated INT to re-analyse samples of 248 
negative and positive controls to confirm the validity of thresholds. This was followed by the final 249 
stage of analysis, in which INT were applied to analyse all other evaluation samples, wherefrom 250 
repeatability, reproducibility and concordance were assessed. At all stages of analysis, samples were 251 
visually inspected via BaseSpace® mtDNA Variant Analyzer v1.0.0 App, which allowed review of 252 
coverage profiles and sequences, as well as export to Excel-format reports. All sample reports were 253 
manually reviewed, and final variant lists (i.e. mitochondrial haplotypes) were produced for sample 254 
comparison, in accordance with the current guidelines [9, 10]. When necessary, BAM files were 255 
reviewed in Integrative Genomics Viewer (IGV) tool v.2.4.16 [32, 33] to resolve ambiguous calls. 256 
 257 
 258 
3. Results and Discussion 259 
3.1. Quality metrics assessment 260 
Evaluation of sequencing quality (Q) metrics is an essential step in sequencing data analysis, since it is 261 
a good indicator of what to expect regarding the quality of results. High metrics quality usually means 262 
better usage of data, therefore more abundant and reliable results. All runs in this study exhibited 263 
excellent quality, as shown in the summary of selected Q metrics parameters (Table 1). Despite the 264 
variations in cluster density (491 – 1062 K/mm2), which were sometimes below the optimal range for 265 
MiSeq Reagent Kit v2 chemistry according to [34, 35], runs maintained high level of quality regarding 266 
9 
 
both the percentage of clusters passing filter (PF) and percentage of bases with Q score equal or higher 267 
than 30 (% Bases ≥Q30; Phred scale). Clusters PF amounted to >90% in all runs, meaning almost all of 268 
the data were always usable for downstream analysis and, judging from % Bases ≥Q30, the great 269 
majority of bases were of sufficiently high quality for downstream analysis (variant calling, eventually). 270 
Suboptimal cluster density in runs 1, 6 and 7 affected total yield and total number of reads PF, which 271 
in turn impacted average read depth per position per sample (Table 1) in the way that validation 272 
samples in these runs received lower average coverage than expected from calculated coverage values 273 
based on chemistry used and targeted region (whole mtDNA). In connection to the cluster density was 274 
also the percentage of reads aligned to PhiX sequencing control (% Aligned). As described earlier, we 275 
used 5% PhiX spike-in, therefore we expected % Aligned to approximate 5%. However, as spike-in 276 
percentage was in fact volume ratio, while % Aligned represented proportion of reads detected as 277 
PhiX reads in the total pool of reads PF, we observed that % Aligned in some runs deviated from the 278 
expected percentage (Table 1). Runs with high cluster density exhibited lower % Aligned and vice versa 279 
(runs with low cluster density contained more PhiX reads). Therefore, % Aligned parameter is directly 280 
dependent on the accuracy of library quantification and subsequent loading concentration: the former 281 
may not be as accurate using gel electrophoresis on LabChip, as opposed to qPCR [36]. The quantity 282 
of libraries may easily be over- or underestimated, thus influencing both their and PhiX’s share in the 283 
total reads available (which is ultimately reflected in % Aligned value). As overclustering poses a risk 284 
to overall success of a sequencing run, we aimed for loading concentrations safely within the 285 
manufacturer’s specifications (ranging 8-15 pM) in order to avoid potential loss of quality. Judging by 286 
almost all Q metrics parameters, runs 2 and 5 displayed optimal values for our data, although the 287 
other runs were only affected in the sense of quantity of results and not the quality, which was still 288 
well above the specifications. 289 
  290 
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Table 1 Summary of selected quality metrics parameters from evaluation runs on MiSeq FGxTM instrument. Values % Bases ≥Q30 and Error rate are given as 291 












% Bases ≥Q30 
Error rate 
(%) 
% Aligned to 
PhiX 
% Reads Identified a 
[Expected %] 
Read depth a, b 
1 24 491 97.8 3.0 9.4 97.1 0.5 13.1 3.9 ± 1.8  [4.2] 5885 ± 3934 
2 24 1062 91.5 5.8 18.5 93.8 0.5 4.8 4.1 ± 1.6  [4.2] 11048 ± 8683 
3 48 864 94.9 5.0 15.9 95.9 0.5 4.1 2.1 ± 0.7  [2.1] 5084 ± 2816 
4 23 939 94.1 5.3 17.0 93.0 0.5 6.5 4.0 ± 1.3  [4.3] 9065 ± 4979 
5 28 948 93.7 5.4 17.1 96.0 0.4 4.8 3.7 ± 0.7  [3.6] 10935 ± 6160 
6 30 539 97.2 3.2 10.1 96.2 0.4 11.2 3.0 ± 0.5  [3.3] 4901 ± 2405 
7 24 551 96.0 3.3 10.6 95.7 0.5 7.6 4.1 ± 1.7  [4.2] 7770 ± 5618 
8 28 745 95.8 4.4 14.0 95.3 0.6 6.1 3.4 ± 1.2  [3.6] 8203 ± 5307 
 293 




Depending on the number of samples multiplexed per sequencing run, there is an expected proportion 296 
of reads identified for each library (e.g. if there are 24 samples in a run, expected percentage of reads 297 
identified is 100/24 = 4.2% of reads assigned to each library, under condition of ideally even 298 
distribution). The values designate proportions of unique index combinations detected in total 299 
amount of reads, and their distribution within runs gives valuable information on the efficiency of the 300 
particular lab’s workflow. In our runs, percentage of reads identified for validation samples closely 301 
approximated the expected values (Table 1). Greater standard deviation was usually observed in runs 302 
where bead-based normalization was applied (runs 1, 2 and 4), as opposed to standard normalization 303 
applied in the remaining runs. It has been noted previously that bead-based normalization introduces 304 
greater variation between libraries [16]. 305 
A drop in quality was generally observed in the second read of paired-end sequencing when compared 306 
to Read 1, manifesting in parameters of % Bases ≥Q30, phasing, prephasing and error rate 307 
(Supplementary Table S2). It is not an uncommon observation, particularly since it is known that in 308 
paired-end sequencing the quality drops both in the second read, as well as towards the end of both 309 
reads [15, 37-39]. Nevertheless, this did not affect the overall quality of sequencing runs, which was 310 
unquestionable. 311 
Regarding the coverage of mtDNA, there was a reproducible pattern across all samples: reads were 312 
unevenly distributed along the entire mitochondrial genome, with extreme drops in coverage at 313 
certain positions (Supplementary Fig. S1), regardless of sample origin (type, person, etc.). This 314 
phenomenon has been reported on numerous occasions [2, 14-16, 40], all including Nextera XT library 315 
preparation. Some read-depleted regions correspond to low-complexity (homopolymer) stretches 316 
that are known as problematic for both sequencing and alignment (e.g. positions 300-600 which 317 
harbour hypervariable segments II and III). However, the cause of coverage drops in other regions (e.g. 318 
positions 3400-3700, 5400-5600, 10900-11000, 13000-13100, 13600-13800) is still unknown. Some 319 
proposed that non-uniform coverage was a by-product of alignment issues because of the circular 320 
reference genome (which was shown not to be the case, after all) [14, 15], and others that it was the 321 
result of the combination of library preparation and challenging alignment [2, 16]. Still others 322 
hypothesized that such coverage pattern resulted from Nextera XT transposome bias [16], i.e. the 323 
enzyme probably preferring certain regions of mtDNA, rather than acting randomly. We are inclined 324 
towards the latter explanation, since we observed almost identical coverage profiles in our libraries 325 
sequenced on NextSeq (data not shown) as part of concordance study, and also because it was shown 326 
that other library preparation chemistry (for example, [40]) produced different, more uniform 327 
coverage pattern. Depending on the purpose, some studies will certainly require different library 328 
preparation approach to achieve the necessary coverage uniformity – for example, uneven coverage 329 
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may be acceptable for population studies (which aim for genotype variants), but less so for minor 330 
allele detection (where sufficient read depth is of paramount importance, and non-uniformity risks 331 
the loss of true variant signal). 332 
 333 
3.2. Contamination study and noise level assessment 334 
Library preparation protocols consist of multiple handling steps, which increase susceptibility to 335 
introduction of exogenous contaminant DNA, facilitate cross-contamination between samples, and 336 
(by means of bead-based purification and normalization) may inflate the amount of eventual 337 
contamination – because of this, some proportion of reads is commonly found (even expected, it 338 
might be said) in NCs [2, 16, 17]. Therefore, it is recommended that NCs be introduced in various 339 
stages during library preparation, to monitor the level of background noise and the presence of 340 
contamination, so that both can be appropriately characterized and the level of tolerance established 341 
– level below which detected noise/contamination has no effect on results and can be classified as 342 
acceptable [2, 9, 10, 16]. To thoroughly assess the level of noise and its contents, as well as to estimate 343 
safe thresholds for reliable data analysis and interpretation, we analysed the total of 35 negative 344 
controls (NCs), sequenced as part of both assessment and other studies carried out on our MiSeq FGx 345 
instrument. Of these, 25 negative controls were reagent blanks introduced in the step of DNA 346 
extraction (NC-EX), six were amplification negative controls from long-range PCR (NC-PCR), and the 347 
remaining four negative controls were reagent blanks introduced in the step of limited-cycle PCR (NC-348 
LIB). 349 
In sequencing pools, NCs were represented with 0.0004-0.0096% of the total number of reads PF. 350 
Detailed analysis of genome VCF files (GVCF) exported from BaseSpace mtDNA Variant Processor 351 
(workflow I in Fig. 1) produced the following results. Signals were detected in total of 206,856 positions 352 
in all 35 NCs, averaging to 5,910 positions per NC covered with both forward and reverse reads. 353 
However, vast majority of these positions (142,395 in total) were detected in NC-EX, out of which 91% 354 
(i.e. 129,393 positions) had read depth of ≤10 reads, while only 47 positions exhibited elevated read 355 
count of >200 reads. NC-PCR and NC-LIB consisted of similar amount of positions with signals detected 356 
(33,699 and 30,762 respectively). 357 
Analyses and calculations were performed both cumulatively for all NCs, for each NC-type separately, 358 
and also for each base (A, C, G, and T) to investigate potential influence of NC-type or particular dye 359 
channel (base detection) on the level and/or nature of noise signals. As shown in Table 2a, maximum 360 
depth (DP) for any NC-EX equalled 1221 reads, which is extremely high, while maximum DP for NC-361 
PCR and NC-LIB was 57 and 21 reads, respectively. By reviewing positions with extreme read DP, we 362 
identified two regions of interest (Fig. 2): 1873-1893 (coding region, 16S rRNA) and 16128-16455 363 
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(control region, HVS-I). Region 1873-1893 showed conspicuous read depth in seven NC-EXs (>1000 364 
reads in one, 100-1000 reads in one, 10-100 reads in five), and in one NC-PCR (40-60 reads). Start and 365 
end coordinates of this region correlated to MTL-R1 primer, used in long-range PCR for amplification 366 
of mtDNA fragment 9.1 kbp. By visualizing BAM files in IGV tool, we confirmed that indeed increased 367 
read depth originated from the primer (Supplementary Fig. S2, upper and middle panels). The 368 
purification of libraries may not have always been equally efficient, depending on the analyst and on 369 
handling the magnetic beads, thus a certain amount of primer might have persisted through to the 370 
sequencing. However, since we detected no signal from any of the other three primers in negative 371 
controls, it is possible this feature is specific to MTL-R1 alone. The discovery of primer signal was quite 372 
surprising, considering that all primer read contributions should have been removed by mtDNA 373 
Variant Processor [27]. For comparison, no primer reads were present in BAM files extracted from 374 
MiSeq Reporter software (Supplementary Fig. S2, lower panel), which indicates that BaseSpace 375 
application’s pipeline may have issues with recognizing and removing this particular primer. Because 376 
of this phenomenon, variants detected in mtDNA positions 1873-1893 must be interpreted with 377 
caution, particularly in case of heteroplasmy calls, since the minor allele signal might in fact originate 378 
from primer reads, instead of true positive variant call from the sample. Most of the times such 379 
ambiguities can be successfully resolved by visual inspection in genome browsers such as IGV. The 380 
second detected region (16128-16455), unlike previous, was not connected to any of the primers used 381 
in long-range PCR, but it was found in eight NC-EX (>100 reads in one, 20-100 reads in others). The 382 
presence of these two regions of increased coverage was more or less random in NC-EX and NC-PCR 383 
(independent of normalization method, analyst, number of libraries per run, etc.), and while it is an 384 
interesting observation, it also warrants caution when interpreting variant calls occurring there. 385 
  386 
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Table 2 Calculations and estimations of read depth analysis threshold, based on negative controls data from: GVCF files (a), GVCF files excluding primer MTL-387 
R1 reads (b), and BaseSpace® mtDNA Variant Analyzer report files (c). Negative controls originated from various stages of the workflow: DNA extraction (NC-388 
EX), mtDNA enrichment (NC-PCR) and library preparation (NC-LIB). Values were calculated for each base separately and then cumulatively, by each NC-type 389 
and also jointly for all NCs. Limit of detection (LOD) value was calculated as: average + 3x standard deviation. Limit of quantitation (LOQ) value was calculated 390 
as: average + 10x standard deviation 391 
 392 
a                        
 NC-EX  NC-PCR  NC-LIB  All NCs 
 A C G T Cum.  A C G T Cum.  A C G T Cum.  A C G T Cum. 
MIN 2 2 2 2 2  2 2 2 2 2  2 2 2 2 2  2 2 2 2 2 
MAX 1221 1197 1205 1196 1221  56 57 56 51 57  20 21 18 20 21  1221 1197 1205 1196 1221 
AVERAGE 6 6 6 6 6  5 5 5 5 5  4 4 4 4 4  6 6 6 5 6 
ST.DEV. 17 13 21 13 15  3 3 3 3 3  2 2 2 2 2  14 11 17 11 13 
LOD 57 45 69 45 51  14 14 14 14 14  10 10 10 10 10  48 39 57 38 45 
LOQ 176 136 216 136 156  35 35 35 35 35  24 24 24 24 24  146 116 176 115 136 
 Read depth threshold estimation = 220 reads 
                        
b                        
 NC-EX  NC-PCR  NC-LIB  All NCs 
 A C G T Cum.  A C G T Cum.  A C G T Cum.  A C G T Cum. 
MIN 2 2 2 2 2  2 2 2 2 2  2 2 2 2 2  2 2 2 2 2 
MAX 213 212 205 216 216  18 19 18 19 19  20 21 18 20 21  213 212 205 216 216 
AVERAGE 6 6 6 6 6  5 5 5 5 5  4 4 4 4 4  5 5 5 5 5 
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ST.DEV. 9 9 7 7 8  3 3 3 3 3  2 2 2 2 2  7 7 6 6 7 
LOD 33 33 27 27 30  14 14 14 14 14  10 10 10 10 10  26 26 23 23 26 
LOQ 96 96 76 76 86  35 35 35 35 35  24 24 24 24 24  75 75 65 65 75 
 Read depth threshold estimation = 100 reads 
                        
c                        
 NC-EX  NC-PCR  NC-LIB  All NCs 
 A C G T Cum.  A C G T Cum.  A C G T Cum.  A C G T Cum. 
MIN 2 2 2 2 2  2 2 2 2 2  2 2 2 2 2  2 2 2 2 2 
MAX 172 155 55 163 182  10 12 11 11 15  11 7 7 7 13  172 155 55 163 182 
AVERAGE 8 10 5 8 12  4 5 5 5 6  4 4 4 4 5  6 9 5 7 10 
ST.DEV. 19 23 6 19 23  2 3 3 3 3  2 2 2 2 3  16 21 5 16 20 
LOD 65 79 23 65 81  10 14 14 14 15  10 10 10 10 14  54 72 20 55 70 
LOQ 198 240 65 198 242  24 35 35 35 36  24 24 24 24 35  166 219 55 167 210 
 Read depth threshold estimation = 240 reads 
  393 
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Comprehensive calculations based on all signals detected in negative controls according to workflow 394 
I (Fig. 1) were made: including primer MTL-R1 reads (Table 2a), and with primer MTL-R1 reads 395 
removed (Table 2b). Results are shown by NC-type, by base for each NC, as well as cumulative values. 396 
Following the more conservative approach, estimation of our internal analytical threshold of read 397 
depth (INT-DP) was based on the highest LOQ value. In the case when primer reads were excluded 398 
(Table 2b), estimated INT-DP equalled 100 reads. However, since primer reads could not be ignored 399 
in the analysis pipeline used, we decided to keep calculations from Table 2a, and estimated INT-DP 400 
accordingly: highest LOQ value was found in NC-EX for base G (216 reads), and by estimating the 401 
threshold at 220 reads, all signals in negative controls would have been eliminated except for the 402 
primer reads (Fig. 2). This actually corresponded well to calculations in Table 2b, because maximum 403 
read depth equalled 216 reads in any negative control after primer contribution was removed. Thus, 404 
INT-DP threshold of 220 reads was applicable both scenarios. 405 
To test the validity of estimated INT-DP threshold, calculations analogous to those described above 406 
were performed on Excel reports data exported from BaseSpace mtDNA Variant Analyzer (workflow 407 
II in Fig. 1). Reports produce lists of variants, i.e. differences from rCRS. Therefore, a large quantity of 408 
signals that are visible in GVCF files are actually not present in Excel reports, which includes primer 409 
reads (as their sequence is identical to rCRS). Nevertheless, reports may be more relevant for 410 
consideration, since a negative control (despite some portion of reads regularly expected) should not 411 
produce any variants, and no variant calls must be present in reports for NCs when validated analysis 412 
threshold is applied. Calculations resulting from negative controls’ BaseSpace reports data (Table 2c) 413 
differ from the results in Table 2a and Table 2b, particularly regarding NC-EX, where greater variation 414 
among bases is evident: larger standard deviation led to higher LOD and LOQ values (highest LOQ=242 415 
reads for cumulative NC-EX, and LOQ=240 reads for C in NC-EX), even though maximum read depth 416 
detected in any NC cumulatively equalled “only” 182 reads. Estimation of read depth threshold at 240 417 
reads, while not considerably higher than 220 reads, would nevertheless be over-conservative, since 418 
by applying the latter threshold all signals from negative controls’ reports could easily be eliminated, 419 
thus establishing the tolerable level of noise below which NCs would be regarded as truly negative. 420 
Considering the content of noise signals, i.e. whether any of the bases (A, C, G, or T) occurred more 421 
often than the other, occurrence of each base was counted from GVCF files (Supplementary Table S3). 422 
Bases A and C were most commonly detected and in almost equal measures, followed by T, while G 423 
was the least commonly detected signal in NCs. This trend was evident in all negative controls, 424 
regardless of the type. However, since the ratio of each base count to the total number of detected 425 
bases (both by NC-type and cumulative) closely approximated its corresponding ratio in mtDNA 426 
(specifically, in rCRS: A=31%, C = 31%, G=13%, T=25%; Supplementary Table S3), we concluded that 427 
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the distribution of noise was random across the entire mtDNA, not preferring any particular base to 428 
the other. 429 
To finalize negative controls assessment, we decided to maintain the estimated read depth threshold 430 
(INT-DP) at 220 reads, which was applicable both in GVCF files analysis and BaseSpace mtDNA Variant 431 
Analyzer reports analysis. The meaning of this thresholds was to set a limit for safe interpretation in 432 
terms of read depth: above the set threshold reliable variant calls can be made, and below is the area 433 
of background noise, contamination and possible erroneous calls. Of course, detection of false positive 434 
signals is always a possibility, but the aim is to minimize that risk with carefully set thresholds, while 435 
at the same time balancing against the loss of true positive signals in the process. 436 
 437 
3.3. Positive controls assessment 438 
For further threshold calculations, samples of positive controls – SRM-C and SRM-H, with known and 439 
previously well characterized sequences [20, 21, 31] – were analysed according to workflow III in Fig. 440 
1. Indels in hypervariable regions (HVS I-III) were ignored at this time, along with point heteroplasmy 441 
variants that were reported in [31], since they cannot be considered as either errors or true variant 442 
calls until validated thresholds are applied. Therefore, indels and PHPs were excluded from 443 
calculations, as well as position 16183 in sample SRM-C. The latter was detected as ambiguous variant 444 
call: a mixture of two bases (A and C) and deletion. It is in fact homoplasmic variant A16183C which, 445 
in conjunction with T16189C (also present in SRM-C), produces uninterrupted homopolymer stretch 446 
of 11 cytosines, resulting in alignment issues, which were reported and elaborated in [31]. As 447 
mentioned earlier, ambiguities such as this may be resolved in most cases by visual inspection of read 448 
alignment in tools such as IGV. 449 
In eight samples (four replicates of each SRM), signals were detected in 3,280 positions, in total. Single 450 
bases (100% variant from rCRS) were called for 194 positions, while in all other positions between one 451 
and three alternative alleles were detected (bases and/or deletions) in addition to the major base. 452 
Calculations were performed cumulatively for all SRMs, and also separately for each base (Table 3). 453 
  454 
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Table 3 Thresholds based on data from BaseSpace® mtDNA Variant Analyzer report files of positive controls SRM-C and SRM-H (SRM® 2392 CHR and SRM® 455 
2392-I HL-60, respectively). Thresholds for read depth and percentage of alternative alleles were calculated and estimated from alternative (non-haplotype) 456 
alleles detected in positive controls (a). Thresholds for genotype (homoplasmic) alleles and quality scores (GQ; Phred scale) were calculated and estimated 457 
from known haplotype variants in positive controls (b). Limit of detection (LOD) value was calculated as: average + 3x standard deviation. Limit of quantitation 458 
(LOQ) value was calculated as: average + 10x standard deviation 459 
 460 
a            
 Read depth  Alternative allele 
 A C G T Cum.  A C G T Cum. 
MIN 2 2 2 2 2  0.1% 0.1% 0.1% 0.1% 0.1% 
MAX 46 449 130 155 449  1.3% 5.5% 0.6% 2.4% 5.5% 
AVERAGE 3 7 4 3 5  0.1% 0.2% 0.1% 0.1% 0.2% 
ST.DEV. 4 20 8 7 12  0.1% 0.5% 0.1% 0.1% 0.3% 
LOD 15 67 28 24 41  0.4% 1.7% 0.3% 0.4% 0.9% 
LOQ 43 207 84 73 125  0.9% 5.1% 0.6% 1.1% 2.8% 
 Estimated read depth threshold = 210  Estimated alternative allele threshold = 3% 
            
b            
 Genotype allele  GQ score 
 A C G T Cum.  A C G T Cum. 
MIN 94.5% 94.0% 99.4% 96.5% 94.0%  25 31 27 27 25 
MAX 100.0% 100.0% 100.0% 100.0% 100.0%  50 50 49 50 50 
AVERAGE 99.8% 99.9% 99.9% 99.9% 99.9%  46 48 46 47 47 
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ST.DEV. 0.4% 0.2% 0.1% 0.2% 0.3%  5 3 4 4 4 
LODa 98.6% 99.2% 99.7% 99.1% 99.0%  
41b 45b 42b 43b 43b 
LOQa 95.8% 97.6% 99.2% 97.5% 97.2%  
 Estimated genotype allele threshold = 97%  Estimated GQ score threshold = 41 
 461 
a Since max. value is 100%, LOD and LOQ calculated as [average - 3x standard deviation] and [average - 10x standard deviation], respectively; b Standard LOD and LOQ formulas 462 
not applicable (since GQ scores are in Phred scale), therefore calculated as: average - 1x standard deviation 463 
  464 
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Regarding read depth calculations for alternative alleles (Table 3a), results were concordant with 465 
those obtained for negative controls, wherefrom estimated coverage threshold (INT-DP) of 220 reads 466 
would be applicable to SRMs as well. Although cumulative LOQ was considerably lower (125 reads), 467 
we decided to keep the minimum read count at 220 reads, since the highest LOQ was calculated for C 468 
(207 reads; Table 3a), which is just short of the estimated negative controls’ threshold (Table 2). As 469 
visible in Fig. 3a, there are two positions where maximum read depth of alternative allele exceeded 470 
the threshold: in particular, variants detected were A2487M and T16189d. However, these two would 471 
not be taken into consideration for true variant calls: the former exhibited extremely poor GQ value 472 
(26-29, Phred score) in both control samples, and the latter consisted of ambiguous calls (C and 473 
deletion, or C and T and deletion) only in SRM-C, mirroring the same problem described above for the 474 
A16183C – in this case, variant T16189C contributed to prolongation of homopolymeric C-stretch and 475 
subsequent issues in alignment. 476 
The other parameter calculated from alternative allele signals was percentage of minor alleles, with 477 
the maximum of 5.5% (Table 3a, Fig. 3b) detected at A2487M – the same position that showed 478 
elevated read depth earlier. Estimating from the cumulative calculated LOQ, analytical threshold for 479 
minor alleles (INT-AN) would be 3%. By applying this threshold, 99% of signals would be successfully 480 
eliminated since in the total of 3,155 alternative alleles detected in all SRMs, only 39 were >1%. 481 
However, as evident from Table 3a and Fig. 3b, alternative alleles with considerably higher minor allele 482 
percentages may occur, and that prompted us to establish additional, interpretation threshold for 483 
minor alleles (INT-IT) which equalled 6%. The meaning of this dual threshold system is as follows: PHP 484 
calls with alternative (minor) alleles >6% are safe for interpretation, under condition of sufficient read 485 
depth; PHPs with minor alleles between 3% and 6% are required to undergo additional scrutiny of 486 
other quality parameters before they are reported; minor alleles <3% are in the area where it is 487 
virtually impossible to distinguish between noise signals and true positive calls (without alternative 488 
confirmation method), therefore they cannot be reported as such. 489 
Regarding variants reported as haplotypes (i.e. genotype alleles, GT), calculations were performed 490 
analogously to the ones described for alternative alleles above (Table 3b). As a result, threshold for 491 
homoplasmic genotype alleles (INT-GT) was estimated at 97% according to cumulative calculations. 492 
Notably, minimum values detected for bases A and C were <97% (94.5% and 94.0%, respectively; Table 493 
3b), but by additional review, we found that minimum signal for A originated from A2487M, a low-494 
quality variant call, while the minimum for C was in fact caused by the sum of two minor alleles  at the 495 
same position (namely, 2.4% T and 3.6% deletion). Overall, we decided to keep the estimated 496 
genotype variant threshold (INT-GT) at 97%, meaning that at any position a variant allele exceeding 497 
97% would be considered homoplasmic, i.e. single base variant call – no PHP call would be allowed for 498 
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this position. This is in accordance with previously calculated minor allele analysis threshold (INT-AN) 499 
of 3%. 500 
In addition to the threshold of percentages for genotype alleles, we performed calculations for quality 501 
values (GQ) of genotype positions (Table 3b). Since the use of standard LOD and LOQ formulas (i.e. 3x 502 
and 10x standard deviations from average, respectively) was not feasible in this case, we opted for a 503 
modified formula more appropriate for the GQ values: average – 1 x standard deviation. Cumulative 504 
GQ threshold (INT-GQ) equalled 43 (Table 3b), however, we decided to keep the threshold at 41 to 505 
accommodate for values of all bases (and calculations for base A produced the value of 41). 506 
Intriguingly, position 2706 exhibited GQ lower than other genotype positions in SRMs (GQ 37-41), but 507 
also in all other analysed samples (GQ values ranging from 33 to 49, of which more than 80% were 508 
<41). Because of this, and similar exceptions to the other threshold components, we must bear in 509 
mind that, for a reliable variant call, thresholds defined for all parameters must be met and considered 510 
as a whole, rather than as individual, independent requirements. 511 
 512 
3.4. Finalized definition of analysis thresholds 513 
Based on the calculations described in previous sections, we finalized the values proposed as our 514 
internally evaluated thresholds (INT) for whole mtDNA analysis, encompassing multiple parameters: 515 
- INT-DP = 220 reads 516 
- INT-GT = 97% 517 
- INT-GQ = 41 518 
- INT-AN = 3% 519 
- INT-IT = 6% 520 
Accordingly, we defined our internal guidelines for whole mtDNA analysis and interpretation as 521 
follows: 522 
- Minimum depth of 220 reads is required for variant allele to be taken for analysis. 523 
- Quality score (GQ) ≥41 is required for a position to be reliable for variant calling. Otherwise, 524 
the position is most likely to contain erroneous variant calls. 525 
- All positions with major allele ≥97% are considered homoplasmic and single base variant is 526 
called. 527 
- Alternative alleles <3% are not analysed nor interpreted, since they reside within the area of 528 
background noise. 529 
- Alternative alleles between 3% and 6% are taken into analysis. They may be interpreted and 530 
subsequently reported, if read depth and quality score thresholds are complied with. 531 
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- Alternative alleles ≥6% are considered safe to interpret and report, since presumably all other 532 
thresholds’ criteria have already been fulfilled. 533 
At first glance, the read depth threshold of minimum 220 reads may seem overly conservative, but its 534 
greatest advantage is that it was derived from our own experimental data, rather than set arbitrarily 535 
or taken at set value from other studies (e.g. [15-17, 40]). Detection of minor allele present at 3% 536 
would hereby require depth of 7,333 reads, while detection of minor allele at 6% would require depth 537 
of 3,667 reads. Despite large read counts, these requirements are easily met, since multiplexing of 24 538 
samples per run gives theoretical coverage of 9,375 reads per position per sample. Even multiplexing 539 
as many as 48 samples per sequencing run gives theoretical coverage of 4,688 reads per position per 540 
sample, which is ample enough for detection of minor alleles with frequencies of 4.7% and higher. The 541 
only obstacle to detection of minor alleles is uneven coverage across the mitochondrial genome, 542 
which displays some chemistry- and sequence-dependent profile, as described earlier. Therefore, 543 
detection and interpretation of minor allele signals in presumably heteroplasmic positions should be 544 
mindful of shortcomings specific to the method used. 545 
In addition to our internal guidelines elaborated above, interpretation and calling of indels should not 546 
be based solely on percentages obtained from BaseSpace mtDNA Variant Analyzer reports. Read 547 
alignments for any indel call are to be manually inspected by visualization in genome browsers such 548 
as IGV, prior to determining the dominant molecule [9], which would be reported as the final variant 549 
call. 550 
Here we presented our approach to the calculation of analysis thresholds, which used multiple-551 
parameter system to define internal guidelines for analysis and interpretation of whole mtDNA MPS 552 
results (something similar has been done in [41] for interpretation of negative controls). As the studies 553 
were performed in a forensic laboratory, the aim was to maintain similarity to the method traditionally 554 
used to derive thresholds in forensic STR markers’ analysis via capillary electrophoresis. As prescribed 555 
by [10], each laboratory should develop and implement their individual interpretation guidelines 556 
based on validation and evaluation studies, which is what we aimed to do here for our own data. This 557 
approach is applicable for other laboratories performing similar studies, but it is possible that the 558 
actual threshold values would slightly vary, since each laboratory presents a unique system with its 559 
staff, equipment, consumables and environment. 560 
 561 
3.5. Repeatability 562 
Definition of repeatability in general terms, according to [7, 8], is the variation in measurements of 563 
results obtained by the same person (analyst) multiple times on the same instrument. This can be 564 
applied two-fold to the sequencing library preparation workflow, since replicates of a sample may 565 
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consist of PCR replicates (same sample amplified in multiple PCR reactions and from each a separate 566 
library prepared) and library replicates (i.e. technical replicates, meaning multiple libraries prepared 567 
from the same PCR reaction of a sample). Having that in mind, we tested repeatability by comparing 568 
final variant calls (final haplotypes) of PCR replicates and library replicates for the samples of buccal 569 
swabs and blood on FTATM Cards (“B” and “F”, respectively) of persons MW-0002 and MW-0020 570 
(schedule in Supplementary Table S1a). Final haplotypes from library replicates of positive controls 571 
SRM-C and SRM-H were compared for repeatability as well. In all instances, indel and heteroplasmy 572 
calls underwent additional review and visual confirmation of read alignment in IGV. Repeatability was 573 
assessed for two analysts separately, to evaluate the variation of library preparation between 574 
different persons handling the protocol. 575 
Library replicates of sample MW-0002-B showed 100% repeatability, regarding final variant calls, for 576 
both Analyst 1 and Analyst 2. PCR replicates of MW-0002-B showed complete repeatability as well, 577 
regardless of analyst. Both library and PCR replicates of sample MW-0002-F exhibited 100% 578 
repeatability, including point heteroplasmy T16311Y, which was consistently called across all 579 
replicates (Supplementary Table S4). In most replicates of sample MW-0020-B, there were two PHPs 580 
consistently detected: T152Y and T9325Y (Supplementary Table S4). The few exceptions occurred in 581 
instances where read depth of the minor allele did not exceed the required threshold of 220 reads, 582 
and thus required manual review below the validated thresholds. In these cases (8 in total; 583 
Supplementary Table S4a and S4b), were it not for multiple replicates for comparison, these calls 584 
would pass as homoplasmic variants. However, for the purpose of this study, presence of minor allele 585 
was considered confirmed, even for those with fewer reads than necessary. For the sample MW-0020-586 
F, only library replicates were made, and they exhibited complete repeatability. One PHP was 587 
detected, T9325Y, which was consistently called in all replicates (Supplementary Table S4b). 588 
Regarding technical replicates of positive controls, SRM-C exhibited 100% repeatability, including one 589 
PHP position (C64Y), which was consistently detected in all three replicates, and is concordant with 590 
[31]. Haplotypes of SRM-H replicates were repeatable as well, altogether with three heteroplasmy 591 
calls: T2445Y, C5149Y and T12071Y. Percentages of minor alleles detected were in accordance with 592 
[31] for all three PHPs. However, only T12071Y was completely repeatable (most likely due to larger 593 
proportion of minor allele), whereas for both other PHPs one or more deficiencies were observed. 594 
Read depth requirement was not met in one of three replicates for both T2445Y and C5149Y, and 595 
manual review was necessary to confirm the presence of minor allele. Besides read depth, 596 
heteroplasmy T2445Y proved more complex to interpret after application of our validated thresholds, 597 
since in all replicates GQ fell below 41 (Supplementary Table S4a) for this position. Upon inspection of 598 
this variant’s environment, we determined that it resides within a region where drop in GQ is 599 
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prominent, in all replicates, and encompasses positions 2412-2487. Thus, we recommend that any 600 
variants be interpreted with caution, as this region is obviously prone to quality issues in general (the 601 
same phenomenon was observed across all samples and sample types). Regarding T2445Y in SRM-H, 602 
since it was detected in all replicates and was described previously [31] – even though the question of 603 
quality was not discussed there – this heteroplasmy was reported and included in repeatability 604 
assessment in this study. Were it not for multiple replicates and literature confirmation, the T2445Y 605 
variant would likely be omitted from final haplotype due to not meeting all threshold criteria. 606 
Overall, 783 variant calls (differences from rCRS) were reviewed in the course of repeatability test, 607 
across 43 replicates in total. For Analyst 1, 564 variant calls were assessed in total, out of which six 608 
calls were discrepant (1.1%). Similarly, in case of Analyst 2, out of 219 variant calls that were assessed 609 
in total, two of them showed discrepancy (0.9%). Thus, repeatability equalled 98.9% and 99.1% for 610 
Analysts 1 and 2, respectively. Since discrepant calls exclusively concerned point heteroplasmies, 611 
whereby manual review confirmed the presence of minor alleles, the whole assay was appraised as 612 
completely repeatable. 613 
 614 
3.6. Reproducibility 615 
Reproducibility study encompassed comparison of haplotypes for two sample types of 11 persons, 616 
along with positive controls SRM-C and SRM-H. Analyst 1 and Analyst 2 independently prepared 617 
batches of libraries, which were sequenced in separate runs. As previously described for repeatability 618 
study, final variant calls (haplotypes) of samples were compared, while indels and heteroplasmy calls 619 
required additional confirmation in IGV tool to be considered for comparison. 620 
Out of 26 pairs of haplotypes that were compared in total, six exhibited some form of discordance and 621 
were manually reviewed to determine the cause. In all cases, the main reason for observed 622 
discrepancies were inconsistently called PHPs in one sample of the pair (Supplementary Table S5). 623 
Samples MW-0078-B, MW-0020-B2, MW-0065-F, MW-0067-F and SRM-H all exhibited 624 
heteroplasmies detected in the results of Analyst 2, while apparently no corresponding heteroplasmy 625 
call was found in results of Analyst 1. The presence of minor alleles, as described in previous section, 626 
was established by manual review below the validated thresholds (220 reads), and in all instances 627 
heteroplasmy calls were confirmed. For the purpose of this study, such results were considered 628 
reproducible. 629 
While the same effect was observed in sample MW-0087-B (variant T8955Y was detected only in one 630 
of the pair, and seemingly no minor allele signal, i.e. 0%, was detected in the other), the cause was 631 
different. To resolve this, we lowered the analysis threshold below 3%, and found minor allele C at 632 
2.9%, despite excellent read depth (396 reads; Supplementary Table S5). Thus, heteroplasmy call was 633 
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considered confirmed for the purpose of reproducibility, even though normally it would not be 634 
detected as PHP since it does not comply with all components of our validated thresholds. 635 
Additionally, to serve as our own internal control sample, MW-0020-B was sequenced in all our runs, 636 
18 times in total (not limited to evaluation runs only). These results were included as part of 637 
reproducibility study, since they encompassed five different analysts who prepared libraries, and 638 
multiple runs. Haplotypes were fully reproducible, regardless of analyst and run, including two PHP 639 
calls, T152Y and T9325Y (Supplementary Table S6). Percentages of minor alleles were consistent with 640 
results from Supplementary Table S4 and Supplementary Table S5. Along with quality (GQ) and read 641 
depth (DP) parameters, they confirm the validity of our “dual” threshold system for analysis and 642 
interpretation, since all PHPs between 3-6% of minor allele conform to other INT components (GQ and 643 
read DP; Supplementary Table S6), and are therefore safe to interpret and report (after analyst review) 644 
according to our validated thresholds. 645 
Overall, the assay produced reproducible results between analysts and different runs. The exceptions 646 
were few cases of inconsistent heteroplasmy calls: of 724 pairs of variants compared for 647 
reproducibility in total, seven pairs required manual analyst review as one of the pair did not meet a 648 
component of thresholds’ criteria. Nonetheless, heteroplasmy calls were eventually confirmed, and 649 
thus considered reproducible as well in this study. 650 
 651 
3.7. Concordance 652 
Concordance study consisted of two parts: firstly, MPS-generated mtDNA haplotypes were compared 653 
to STS results (published previously as part of Croatian population study [26]); and secondly, MiSeq-654 
generated results were compared to NextSeq-generated results, obtained by the same library 655 
preparation reagents, but sequenced in an independent laboratory on a different instrument. 656 
 657 
3.7.1. MPS to STS 658 
We compared haplotypes of 10 persons’ buccal swabs used in this study to their corresponding 659 
haplotypes generated by STS. The latter encompassed only mtDNA control region, while in this study 660 
we sequenced whole mtDNA. In general, results were concordant (Supplementary Table S7), with few 661 
exceptions concerning PHP calls, as well as insertions. For example, insertions at position 573 were 662 
regularly detected in ranges of 3-10% (as reported in Excel reports from BaseSpace mtDNA Variant 663 
Analyzer application), which is far below the 50% required to call the dominant molecule. However, 664 
these percentages may not reflect the actual state: they may have been artificially produced (or, 665 
rather, reduced) by alignment artefacts. Therefore, by viewing read alignments via IGV tool, we were 666 
able to resolve apparent discrepancies between STS and MPS: insertions 573.1C-573.3C were 667 
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confirmed in MW-0012, insertions 573.1C-573.4C confirmed in MW-0026 and MW-0067, insertion 668 
16193.1C confirmed in MW-0065, and insertions 16193.1C-16193.2C confirmed in MW-0078. The 669 
presence of insertions was sufficient to appraise results as concordant, since length variation cannot 670 
be counted as exclusion [9, 10], or discordance in this case. 671 
Apart from indel calls, which were manually reviewed and confirmed, point heteroplasmies were the 672 
main source of discrepancies, as expected, since MPS readily detects minor alleles below 10%, which 673 
is the nominal sensitivity of detection for STS method. Thus, samples MW-0020, MW-0067, MW-0087 674 
and MW-0088 exhibited PHPs that were not seen previously in STS results: T152Y, C16301Y, A374R 675 
and C16256Y, respectively (Supplementary Table S7). These observations were not unexpected, since 676 
in all four PHPs minor allele proportions were <10% (Supplementary Table S5), and thus passed 677 
undetected by STS. Furthermore, samples MW-0026, MW-0065 and MW-0078 exhibited 678 
homoplasmic variants in STS results (T16093C, T16093C and A200G), whereas MPS revealed these 679 
positions as actually heteroplasmic (Supplementary Table S5 and Supplementary Table S7). Minor 680 
allele T might have been detected by STS in sample MW-0026, since proportions from STS results 681 
exceeded 11%, however, the observation was probably not sufficiently confident for the PHP call. 682 
In general, MPS-generated results were concordant with STS-generated results, with few exceptions 683 
like indels and PHP calls, the first due to MPS method limitations (bioinformatic solutions still struggle 684 
with homopolymeric nucleotide stretches and other low complexity regions, thus creating artificial 685 
image of indels), and the latter due to STS method limitations (sensitivity of minor allele detection). 686 
Besides comparison of control region haplotypes, MPS of whole mtDNA evidently generates much 687 
more information and greatly complements STS data. It is particularly elucidating to see the number 688 
of variants arising in the coding region, as well as the appearance of more heteroplasmic positions. 689 
This gain of discriminatory information is particularly relevant for forensic purposes. 690 
 691 
3.7.2. MPS to MPS (MiSeq to NextSeq) 692 
To validate our whole mtDNA MPS results, 36 pairs of haplotypes were compared for concordance 693 
assessment between two MPS platforms: MiSeq FGx in our laboratory and NextSeq in an independent 694 
laboratory (Supplementary Table S1d). MiSeq data were analysed at the established INT thresholds, 695 
with indels and heteroplasmy calls subsequently reviewed via IGV tool as described previously. The 696 
exact same analysis thresholds, however, could not be applied to data from NextSeq instrument – 697 
different instrument, different operators, and different laboratory environment – at least not without 698 
conducting a separate evaluation to establish thresholds specific to that instrument’s conditions, 699 
which was beyond the scope of this study. Therefore, all variants detected on MiSeq and reported in 700 
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final haplotypes of samples only sought confirmation in the NextSeq data, and not complete 701 
compliance with the calculated INT thresholds. 702 
The majority of samples showed absolute concordance between results from the two sequencing 703 
platforms. Some minor discrepancies were noted, arising from heteroplasmy calls (Supplementary 704 
Table S8). For samples MW-0020-B and SRM-H, which had two and three PHPs detected, respectively, 705 
one of the three library replicates of each sample exhibited low coverage of minor alleles in MiSeq 706 
results (read depth <220 reads; Supplementary Table S8). Normally, if that one replicate were uniquely 707 
sequenced sample either for MW-0020-B or SRM-H, MiSeq calls would not have been defined as 708 
heteroplasmies, but as single variants. However, since these particular variants were detected in all 709 
other replicates of MW-0020-B and SRM-H, multiple times during repeatability and reproducibility 710 
studies (Supplementary Tables S4-S6), here they were acknowledged as PHPs as well. The presence of 711 
minor alleles for all PHPs in those two samples were unambiguously confirmed in NextSeq results, 712 
which offered much better coverage, and subsequently easier interpretation. 713 
Further, in all three replicates of sample MW-0020-F, variant T9325Y was underrepresented in the 714 
NextSeq data, regarding both minor allele percentage and read depth (<3% and <220 reads, 715 
respectively). It is worth noting that these replicates received less than average share of reads: 0.07-716 
0.57% reads identified, while approximately 1% would be expected since 96 samples were multiplexed 717 
for the NextSeq run. Consequently, read depth was lower in these samples, and some variants were 718 
very poorly covered (e.g. only 22 reads for minor allele C in replicate MW-0020-F2). Regardless of that, 719 
the presence of minor allele was established in all replicates and was sufficient for the confirmation 720 
of concordance. By the same analogy, heteroplasmy C16301Y in sample MW-0067-F showed minor 721 
allele at 2.9% in the NextSeq dataset, and though it may be below the established thresholds on 722 
MiSeq, it was not considered as a discordance since the confirmation was all that we needed from 723 
NextSeq. 724 
In contrast to reproducibility study (Supplementary Table S5), sample MW-0080-B showed additional 725 
heteroplasmy call (T16093Y). Probably it passed undetected earlier because of poor read depth and/or 726 
minor allele <3%. However, it was now detected on MiSeq, and also confirmed in its corresponding 727 
pair mate in NextSeq results (Supplementary Table S8). Adversely, samples MW-0087-B and MW-728 
0065-F experienced a loss of heteroplasmy call (T8955Y and T16093Y, respectively), in comparison to 729 
reproducibility study results (Supplementary Table S5), as their respective minor alleles probably 730 
lacked either read depth or percentage to be detected. These observations were not surprising for 731 
neither of these samples, since all three heteroplasmies exhibited minor allele proportions on the 732 
borderline of the defined analysis thresholds for MiSeq data (very close to 3%), and thus may or may 733 
not be detected, which strongly depends on sequencing run metrics in each particular case. 734 
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Overall, comparison of sequencing results comprised the total of 955 pairs of variants (differences 735 
from rCRS) between two MPS platforms. In several instances, manual review was required before 736 
confirmation of results, but they were all successfully resolved. Both datasets unequivocally showed 737 
complete concordance, as expected, since both instruments originate from the same manufacturer, 738 
and are based on the same sequencing-by-synthesis technology. 739 
 740 
3.8. Mixtures study 741 
As part of the repeatability study, but also to test the reliability of minor allele detection in 742 
heteroplasmy calls, as well as to discriminate between true PHPs and mixture, we prepared simulated 743 
forensic mixed samples (Supplementary Table S1c). Buccal swab samples of two female persons MW-744 
0002 and MW-0020 were selected, since they were previously used for repeatability studies, thus 745 
sequenced multiple times, and their sequence was by now well known. They were combined in the 746 
ratios 1:199 (MIX-1 = 0.5%), 1:99 (MIX-2 = 1.0%), 1:39 (MIX-3 = 2.5%) and 1:19 (MIX-4 = 5.0%). Mixed 747 
samples underwent long-range PCR (three replicates each) and library preparation protocol as 748 
previously described for all other validation samples. The two haplotypes differed in exactly 12 749 
positions (4 in control region, 8 in coding region; Supplementary Table S7), which we targeted for 750 
analysis with the lowered thresholds. Other positions were not eligible for analysis and interpretation, 751 
since mixture ratios were mostly below the thresholds established by this evaluation. 752 
Read depth for the targeted positions varied (minimum 1,461 reads; maximum 30,102 reads), but in 753 
all instances it was sufficient for the detection of minor contributor at the expected ratios. Minor 754 
contributor was successfully detected in all mixtures at the expected mtDNA positions. However, 755 
percentages of minor contributor alleles differed from the theoretical values: on average, in all four 756 
mixtures minor contributor was detected in excess to the expected ratio (Table 4). It was interesting 757 
to note that at positions 2259, 4745 and 14872 minor contributor alleles were detected with as much 758 
as twice the expected ratio (e.g. 1% instead of 0.5%, 10% instead of 5%, etc.). This particular position-759 
specific phenomenon remains inexplicable, since these mtDNA positions do not reside within error-760 
prone regions, neither does the major contributor exhibit additional PHPs at these coordinates which 761 
would tilt the ratios to such extent. Contributing to this unusual phenomenon is the fact that NextSeq 762 
results (as mixtures were sequenced alongside other samples in concordance study) showed identical 763 
trend, and almost identical values, among minor contributor ratios, for exactly the same three 764 
positions (data not shown). 765 
  766 
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Table 4 Proportion of minor contributor alleles per each of 12 mtDNA positions differing between samples MW-0002 and MW-0020 used in the mixtures 767 




72 2259 2706 4745 5897 7028 13680 14872 15904 16231 16298 16359       
rCRS base T C A A C C C C C T T T       
Major 
allele 
T T A G C C T T C T T T       
Minor 
allele 
C C G A T T C C T C C C  
Observed 






MIX-1-1 0.7% 0.9% 0.6% 1.1% 0.5% 0.6% 0.3% 0.7% 0.5% 0.6% 0.5% 0.6%  
0.7 ± 0.2 % 0.5% 
 
1:135 1:199 MIX-1-2 1.1% 1.0% 0.7% 1.2% 0.7% 0.9% 0.7% 0.9% 0.7% 0.9% 0.7% 0.8%   
MIX-1-3 0.7% 0.9% 0.6% 1.2% 0.6% 0.5% 0.6% 0.9% 0.6% 0.9% 0.6% 0.6%   
MIX-2-1 1.4% 2.1% 1.2% 2.8% 1.4% 1.5% 0.7% 1.5% 1.2% 1.4% 0.9% 1.4%  
1.3 ± 0.4 % 1.0% 
 
1:76 1:99 MIX-2-2 1.3% 1.3% 1.1% 2.0% 1.0% 1.3% 1.1% 1.6% 1.3% 1.5% 1.1% 1.2%   
MIX-2-3 1.1% 1.6% 1.2% 1.7% 1.1% 1.3% 0.9% 1.2% 1.0% 1.3% 0.9% 1.0%   
MIX-3-1 3.2% 4.8% 2.9% 5.3% 3.2% 3.5% 2.0% 3.1% 3.1% 3.2% 2.2% 2.6%  
3.3 ± 0.7 % 2.5% 
 
1:31 1:39 MIX-3-2 3.3% 4.4% 3.3% 4.5% 3.2% 3.6% 2.4% 3.8% 3.1% 3.5% 2.5% 2.9%   
MIX-3-3 3.2% 4.0% 2.6% 4.5% 2.9% 3.1% 2.5% 3.7% 2.9% 3.2% 2.2% 2.8%   
MIX-4-1 6.6% 9.0% 5.4% 9.4% 6.1% 6.7% 4.2% 8.2% 6.3% 6.7% 5.0% 6.0%  
6.5 ± 1.6 % 5.0% 
 
1:15 1:19 MIX-4-2 6.4% 8.4% 5.1% 9.8% 6.1% 6.5% 4.1% 7.2% 5.8% 6.6% 4.7% 5.6%   
MIX-4-3 6.2% 8.9% 5.5% 10.6% 6.0% 6.7% 4.4% 7.1% 5.5% 6.4% 4.5% 5.6%   
  770 
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One possible explanation for the difference between average observed minor contributor ratios and 771 
expected values is that it might have been caused by bias during long-range PCR: one contributor’s 772 
mtDNA might have been amplified more efficiently than the other’s. This would introduce slight 773 
change to the ratio of contributors from the start and eventually it would manifest itself in the results. 774 
Alternatively, as indicated in [17], the skewed observed ratios may more likely be the product of 775 
differences in mtDNA vs. nDNA quantity between samples: in that case, expected mixture ratios 776 
calculated from genomic DNA concentrations would not exactly correspond to the final results where 777 
mtDNA to mtDNA ratios were observed. Notwithstanding, whole mtDNA workflow in general consists 778 
of multiple steps wherein ratios of contributors may be affected. Thus, even though sequencing is 779 
reproducible and relatively precise, this method is not suitable for accurate detection of the 780 
proportion of minor contributor in mixed samples, as multiple preparation steps, in combination with 781 
the content of mtDNA within the sample, may introduce bias to the ratio of contributors. 782 
Besides detection of minor contributor, we monitored the presence of two PHPs characteristic to the 783 
buccal swab sample of MW-0020, as described in previous sections (Supplementary Tables S4-S6). 784 
Both heteroplasmies (T152Y and T9325Y) were consistently called in all mixtures (Supplementary 785 
Table S9), regardless of the proportion of minor contributor, and their respective values correspond 786 
well to the minor allele percentages reported in previous experiments of this study. 787 
 788 
 789 
4. Conclusion 790 
Based on multi-component criteria of data analysis thresholds (in terms of read depth, percentage of 791 
alleles and quality scores), which were established in this study, we defined internal guidelines for 792 
analysis and interpretation of mtDNA results obtained by MPS. The proposed methodology proved 793 
robust and confident for variant calling and reporting when applied to analysis of controls and samples 794 
alike. Our study also shows that the whole mtDNA assay on MiSeq FGxTM produces repeatable and 795 
reproducible results (both between runs for the same analyst, and between different analysts) for all 796 
samples, equally for buccal swabs and blood samples, as well as for cell-culture-derived positive 797 
control samples (SRMs 2392 and 2392-I). Moreover, results were completely concordant with STS 798 
results [26], and were also concordant with results obtained on another MPS platform. Few minor 799 
discrepancies were observed, originating from heteroplasmy calls that did not comply with at least 800 
one component of defined analysis thresholds, but all calls were eventually confirmed in both datasets 801 
after analyst review; thus, no major discordance was noted. We conclude that this assay – including 802 
enrichment strategy, library preparation reagents, sequencing reagents, sequencing instrument and 803 
accompanying analysis software – is suitable for further use in our forensic laboratory. It will be further 804 
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used for Croatian population study on whole mitochondrial genomes, in order to establish a national 805 
database for the purpose of haplotype and haplogroup frequencies. 806 
Some features of the analysis software may require additional attention in future upgrades, for 807 
example, dealing with leftover primer reads, treatment of indels and homopolymeric regions (a 808 
common struggle to almost every mtDNA analysis program), accommodation of forensic 809 
mitochondrial nomenclature, and also making more parameters available for user-modification in 810 
order to better tailor the analysis to specific study goals. All in all, Illumina® BaseSpace® Sequence Hub 811 
online bioinformatics platform is, at present, an acceptable solution for fast, intuitive, high-throughput 812 
data analysis which will be required for the population study.  813 
Free online, cloud-based platforms such as BaseSpace®, with its plethora of applications, can be user-814 
friendly, require little previous bioinformatic knowledge, and provide simple, fast, cost-effective 815 
solutions to streamline both data analysis and data storage. However, online solutions are unsuitable 816 
in a forensic setting, where data handling procedures are strictly prescribed by laws and protocols, 817 
dedicated off-line servers are used for analysis and storage of sensitive case-related information and 818 
analysis results in order to maintain their confidentiality, etc. Considering that, at some point in the 819 
future, whole mtDNA analysis by MPS will be implemented into routine forensic casework, the choice 820 
of analysis software will have to be reconsidered. Therefore, it is imperative that, in parallel to the 821 
population study, in the future, a comparison of other available analysis software be conducted, in 822 
order to decide the best bioinformatics solution for casework samples. Needless to say, they provide 823 
more challenge than reference samples used in evaluation and population studies, and would thus 824 
require a different approach not only in terms of analysis software, but in library preparation method 825 
as well. 826 
  827 
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Figure captions 931 
Fig. 1 Schematic diagram of analysis steps performed on samples of negative and positive controls. All 932 
controls underwent analysis in BaseSpace® mtDNA Variant Processor using identical thresholds. 933 
Genome variant call format (GVCF) files were perused in detail only for negative controls. Excel reports 934 
were perused both for negative and positive controls. After performed calculations, internal analysis 935 
and interpretation thresholds (INT) were defined and estimated conservatively 936 
Abbreviations: F = forward; R = reverse; MIN = minimum value; MAX = maximum value; AVERAGE = 937 
mean (average) value; STDEV = standard deviation; LOD = limit of detection; LOQ = limit of 938 
quantitation; NC = negative control; SRM-C = SRM® 2392 CHR; SRM-H = SRM® 2392-I HL-60; PHP = 939 
point heteroplasmy 940 
 941 
Fig. 2 Maximum read depth per mtDNA position of all signals detected in negative controls. Two 942 
regions of interest (i.e. with conspicuously high read coverage) are marked with arrows: primer MTL-943 
R1 coordinates (1873-1893) and part of hypervariable region HVS-I (16128-16455) 944 
 945 
Fig. 3 Graphical representation of maximum read depth of alternative alleles per position (a) and 946 
maximum percentage (%) of alternative alleles per position (b) in positive control samples (SRM® 2392 947 
CHR and SRM® 2392-I HL-60). Extremes detected in positions 2487 and 16189 (on both graphs) are 948 
marked with arrows 949 
 950 
 951 
Supplementary material description 952 
Electronic supplementary material file contains: 953 
- Fig. S1: coverage profiles of selected samples (NIST SRM® controls, buccal swab and blood 954 
samples), with highlighted areas exhibiting coverage drops; 955 
- Fig. S2: visualization of primer MTL-R1 reads in negative controls, via IGV tool; 956 
- Table S1: outline of evaluation experiments: repeatability, reproducibility, mixtures and 957 
concordance studies; 958 
- Table S2: comparison of sequencing quality metrics for Read 1 and Read 2; 959 
- Table S3: base counts and their respective proportions in signals detected in negative controls; 960 
- Table S4: repeatability study results for point heteroplasmy calls detected in samples included 961 
in the study; 962 
- Table S5: reproducibility study results for point heteroplasmy calls detected in samples 963 
included in the study; 964 
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- Table S6: reproducibility results of point heteroplasmy calls in sample MW-0020 sequenced 965 
in all runs; 966 
- Table S7: comparison of samples’ haplotypes generated in this study to Sanger-type 967 
sequencing results; 968 
- Table S8: concordance results of samples’ point heteroplasmy calls between MiSeq FGxTM and 969 
NextSeq®500 platforms; 970 
- Table S9: detected proportions of minor allele in point heteroplasmy calls of sample MW-0020 971 
(major contributor in mixtures). 972 
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